Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-16

Clinical Trial Update: Ibuprofen vs Expectant Management for hsPDA in Preterm Infants: Retrospective Cohort

View source ↗

Summary

A retrospective cohort study comparing ibuprofen treatment to expectant management for hemodynamically significant patent ductus arteriosus in preterm infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Shengjing Hospital | Conditions: Patent Ductus Arteriosus, Infant, Premature | Status: COMPLETED